placenta Antibody

placenta Antibody

Placenta Growth Factor (PGF) Antibody

abx028155-400ul Abbexa 400 ul 627.6 EUR

Placenta Growth Factor (PGF) Antibody

abx028155-80l Abbexa 80 µl 343.2 EUR

Placenta Growth Factor (PGF) Antibody

abx001442-100l Abbexa 100 µl 400 EUR

Placenta Growth Factor (PGF) Antibody

abx001442-20l Abbexa 20 µl 175 EUR

Placenta Growth Factor (PGF) Antibody

abx001442-50l Abbexa 50 µl 275 EUR

Placenta Growth Factor (PGF) Antibody

abx306392-100g Abbexa 100 µg 362.5 EUR

Placenta Growth Factor (PGF) Antibody

abx306392-20g Abbexa 20 µg 162.5 EUR

Placenta Growth Factor (PGF) Antibody

abx306392-50g Abbexa 50 µg 250 EUR

Placenta Growth Factor (PGF) Antibody

abx028155-400l Abbexa 400 µl 518.75 EUR

Placenta Growth Factor (PGF) Antibody

abx402216-250g Abbexa 250 µg 287.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx433146-200ul Abbexa 200 ul 460.8 EUR

Placenta Growth Factor (PLGF) Antibody

20-abx174070 Abbexa
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx174071 Abbexa
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178023 Abbexa
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx178024 Abbexa
  • Ask for price
  • Ask for price
  • 1 mg
  • 200 ug

Placenta Growth Factor (PLGF) Antibody

20-abx142140 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

Placenta Growth Factor (PLGF) Antibody

20-abx102283 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102284 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

20-abx102285 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Growth Factor (PLGF) Antibody

abx102283-100l Abbexa 100 µl 200 EUR

Placenta Growth Factor (PLGF) Antibody

abx102283-1ml Abbexa 1 ml 462.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx102283-200l Abbexa 200 µl 250 EUR

Placenta Growth Factor (PLGF) Antibody

abx102284-100l Abbexa 100 µl 212.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx102284-1ml Abbexa 1 ml 500 EUR

Placenta Growth Factor (PLGF) Antibody

abx102284-200l Abbexa 200 µl 262.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx102285-100l Abbexa 100 µl 262.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx102285-1ml Abbexa 1 ml 725 EUR

Placenta Growth Factor (PLGF) Antibody

abx102285-200l Abbexa 200 µl 337.5 EUR

Placenta Growth Factor (PLGF) Antibody

abx174070-1ml Abbexa 1 ml 625 EUR

Placenta Growth Factor (PLGF) Antibody

abx174071-100l Abbexa 100 µl 775 EUR

Placenta Growth Factor (PLGF) Antibody

abx174071-1ml Abbexa 1 ml Ask for price

Placenta Growth Factor (PLGF) Antibody

abx174071-200l Abbexa 200 µl Ask for price

Placenta Specific Protein 8 (PLAC8) Antibody

20-abx313859 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx307413 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx132127 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Specific Protein 8 (PLAC8) Antibody

abx236511-100ug Abbexa 100 ug 577.2 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

20-abx102925 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Placenta Specific Protein 9 (PLAC9) Antibody

abx307413-100g Abbexa 100 µg 362.5 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx307413-20g Abbexa 20 µg 162.5 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx307413-50g Abbexa 50 µg 250 EUR

Placenta Specific Protein 8 (PLAC8) Antibody

abx236511-100g Abbexa 100 µg 350 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx132127-100tests Abbexa 100 tests 300 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx102925-100l Abbexa 100 µl 287.5 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx102925-1ml Abbexa 1 ml 825 EUR

Placenta Specific Protein 9 (PLAC9) Antibody

abx102925-200l Abbexa 200 µl 362.5 EUR

Placenta Specific Protein 8 (PLAC8) Antibody

abx313859-100g Abbexa 100 µg 362.5 EUR

Placenta Specific Protein 8 (PLAC8) Antibody

abx313859-20g Abbexa 20 µg 162.5 EUR

Placenta Specific Protein 8 (PLAC8) Antibody

abx313859-50g Abbexa 50 µg 250 EUR

Placenta Growth Factor (PGF) Antibody (HRP)

20-abx306393 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta Growth Factor (PGF) Antibody (HRP)

abx306393-100g Abbexa 100 µg 362.5 EUR

Placenta Growth Factor (PGF) Antibody (HRP)

abx306393-20g Abbexa 20 µg 162.5 EUR

Placenta Growth Factor (PGF) Antibody (HRP)

abx306393-50g Abbexa 50 µg 250 EUR

Placenta Growth Factor (PGF) Antibody (FITC)

20-abx306394 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

PLGF Antibody / PGF / Placenta Growth Factor

RQ4653 NSJ Bioreagents 100ug 356.15 EUR
Description: Placental growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

Plgf Antibody / Pgf / Placenta growth factor

R32889 NSJ Bioreagents 100 ug 356.15 EUR
Description: Placenta growth factor (PGF, also known as PLGF) codes for an angiogenic factor expressed in placental tissue that is similar to vascular permeability factor/vascular endothelial growth factor (VPF/VEGF). It is a glycosylated dimeric secreted protein able to stimulate endothelial cell growth in vitro. PGF is located on chromosome 14 and has been conserved in evolution. It belongs to the family of vascular endothelial growth factors (VEGFs) and binds to the flt-1 VEGF receptor. PLGF-2, which is a PLGF isoform, binds neuropilin-1 and 2 in a heparin-dependent manner. PGF regulates inter- and intra molecular cross talk between the VEGF RTKs Flt1 and Flk1 and stimulates the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Moreover, it plays an important role in pathological angiogenic events and with exerting its biological activities through binding to VEGFR1.

PLGF Antibody / PGF / Placenta Growth Factor

V2223-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V2223SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include fibroblast-, platelet derived-, vascular endothelial- and placenta- growth factor (PLGF). Like vascular endothelial growth factor, several PLGF variants have been shown to arise from alternative mRNA splicings. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161-20UG NSJ Bioreagents 20 ug 186.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

PLGF Antibody / PGF / Placenta Growth Factor

V3161SAF-100UG NSJ Bioreagents 100 ug 424.15 EUR
Description: The onset of angiogenesis is believed to be an early event in tumorigenesis and may facilitate tumor progression and metastasis. Several growth factors with angiogenic activity have been described. These include Fibroblast Growth Factor (FGF), Platelet Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PLGF). Placenta growth factor (PLGF) is a secreted protein primarily produced by placental trophoblasts but also expressed in other endothelial cells and tumors. There are three isoforms, PLGF-1, PLGF-2, and PLGF-3. PLGF-2 is expressed up until week 8 in the placenta; the placental tissues continuously express PLGF-1 and PLGF-3 but only PLGF-1 is found in colon and mammary carcinomas. PLGF acts to stimulate angiogenesis, endothelial growth and migration. PLGF is a powerful promoter of tumor growth and is upregulated in some cancers, and PLGF is thought to aid in atherosclerotic lesions and neovascular growth surrounding the lesion. Also, PLGF appears to aid aldosterone mediated atherosclerosis. Serum levels of PLGF in some cases are used as a potential biomarker for disease or genetic defect. Recent research indicates that PLGF levels are lower in mothers with Down syndrome fetuses. Evidence has suggested VEGF to be an obligatory component in PLGF signaling. While VEGF homodimers and VEGF/PLGF heterodimers function as potent mediators of mitogenic and chemotactic responses in endothelial cells, PLGF homodimers are effectual only at extremely high concentrations. Indeed, many of the physiological effects attributed to VEGF may actually be a result of VEGF/PLGF. VEGF and PLGF share a common receptor, Flt-1, and may also activate Flk-1/KDR.

Placenta Growth Factor (PGF) Antibody (FITC)

abx306394-100g Abbexa 100 µg 362.5 EUR

Placenta Growth Factor (PGF) Antibody (FITC)

abx306394-20g Abbexa 20 µg 162.5 EUR

Placenta Growth Factor (PGF) Antibody (FITC)

abx306394-50g Abbexa 50 µg 250 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

20-abx310990 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Placenta-Specific Protein 1 (PLAC1) Antibody

abx036602-100ug Abbexa 100 ug 469.2 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 1 (PLAC1) Antibody

abx030937-80l Abbexa 80 µl 343.2 EUR

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-400ul Abbexa 400 ul 627.6 EUR

Placenta-Specific Protein 4 (PLAC4) Antibody

abx028782-80l Abbexa 80 µl 343.2 EUR

PLAC9 Antibody / Placenta-specific protein 9

RQ4388 NSJ Bioreagents 100 ug 356.15 EUR
Description: By microarray assay to search for mouse genes enriched in placenta, Plac9 was identified as a placenta-enriched gene expressed in mouse 16-cell morula cDNA. By database analysis, human PLAC9, which encodes a deduced 97-amino acid protein, was identified. The deduced 108-amino acid mouse protein has a predicted signal peptide, a coiled-coil domain, and shares 73% identity with human PLAC9. Northern blot analysis of mouse placenta and embryo RNA at 12.5 and 18.5 days postcoitum (dpc) detected predominant expression in placenta.

Placenta-Specific Protein 1 (PLAC1) Antibody

abx310990-100g Abbexa 100 µg 362.5 EUR